PYRROLOPYRIMIDINE COMPOUNDS AS CDK INHIBITORS
The disclosed compounds relate to treatments and therapies for protein kinase-associated disorders. There is also a need for compounds useful in the treatment or prevention or amelioration of one or more symptoms of cancer, transplant rejections, and autoimmune diseases. Furthermore, there is a need...
Gespeichert in:
| Hauptverfasser: | , , , , , |
|---|---|
| Format: | Patent |
| Sprache: | eng ; por |
| Schlagworte: | |
| Online-Zugang: | Volltext bestellen |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | |
|---|---|
| container_issue | |
| container_start_page | |
| container_title | |
| container_volume | |
| creator | GILBERT BESONG CLINTON A. BROOKS CHRISTOPHER THOMAS BRAIN CLAUDIO DAGOSTIN MILES STUART CONGREVE GUO HE |
| description | The disclosed compounds relate to treatments and therapies for protein kinase-associated disorders. There is also a need for compounds useful in the treatment or prevention or amelioration of one or more symptoms of cancer, transplant rejections, and autoimmune diseases. Furthermore, there is a need for methods for modulating the activity of protein kinases, such as CDK1, CDK2, CDK4, CDK5, CDK6, CDK7, CDK8 and CDK9, using the compounds provided herein. |
| format | Patent |
| fullrecord | <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_PT2331547EE</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>PT2331547EE</sourcerecordid><originalsourceid>FETCH-epo_espacenet_PT2331547EE3</originalsourceid><addsrcrecordid>eNrjZNANiAwK8vfxB1Kevp4unn6uCs7-vgH-oX4uwQqOwQrOLt4Knn4enk6eIf5BwTwMrGmJOcWpvFCam0HBzTXE2UM3tSA_PrW4IDE5NS-1JD4gxMjY2NDUxNzV1ZgIJQCxgyXG</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>PYRROLOPYRIMIDINE COMPOUNDS AS CDK INHIBITORS</title><source>esp@cenet</source><creator>GILBERT BESONG ; CLINTON A. BROOKS ; CHRISTOPHER THOMAS BRAIN ; CLAUDIO DAGOSTIN ; MILES STUART CONGREVE ; GUO HE</creator><creatorcontrib>GILBERT BESONG ; CLINTON A. BROOKS ; CHRISTOPHER THOMAS BRAIN ; CLAUDIO DAGOSTIN ; MILES STUART CONGREVE ; GUO HE</creatorcontrib><description>The disclosed compounds relate to treatments and therapies for protein kinase-associated disorders. There is also a need for compounds useful in the treatment or prevention or amelioration of one or more symptoms of cancer, transplant rejections, and autoimmune diseases. Furthermore, there is a need for methods for modulating the activity of protein kinases, such as CDK1, CDK2, CDK4, CDK5, CDK6, CDK7, CDK8 and CDK9, using the compounds provided herein.</description><language>eng ; por</language><subject>CHEMISTRY ; HETEROCYCLIC COMPOUNDS ; HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; METALLURGY ; ORGANIC CHEMISTRY ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><creationdate>2014</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20141029&DB=EPODOC&CC=PT&NR=2331547E$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,776,881,25542,76289</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20141029&DB=EPODOC&CC=PT&NR=2331547E$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>GILBERT BESONG</creatorcontrib><creatorcontrib>CLINTON A. BROOKS</creatorcontrib><creatorcontrib>CHRISTOPHER THOMAS BRAIN</creatorcontrib><creatorcontrib>CLAUDIO DAGOSTIN</creatorcontrib><creatorcontrib>MILES STUART CONGREVE</creatorcontrib><creatorcontrib>GUO HE</creatorcontrib><title>PYRROLOPYRIMIDINE COMPOUNDS AS CDK INHIBITORS</title><description>The disclosed compounds relate to treatments and therapies for protein kinase-associated disorders. There is also a need for compounds useful in the treatment or prevention or amelioration of one or more symptoms of cancer, transplant rejections, and autoimmune diseases. Furthermore, there is a need for methods for modulating the activity of protein kinases, such as CDK1, CDK2, CDK4, CDK5, CDK6, CDK7, CDK8 and CDK9, using the compounds provided herein.</description><subject>CHEMISTRY</subject><subject>HETEROCYCLIC COMPOUNDS</subject><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>METALLURGY</subject><subject>ORGANIC CHEMISTRY</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2014</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZNANiAwK8vfxB1Kevp4unn6uCs7-vgH-oX4uwQqOwQrOLt4Knn4enk6eIf5BwTwMrGmJOcWpvFCam0HBzTXE2UM3tSA_PrW4IDE5NS-1JD4gxMjY2NDUxNzV1ZgIJQCxgyXG</recordid><startdate>20141029</startdate><enddate>20141029</enddate><creator>GILBERT BESONG</creator><creator>CLINTON A. BROOKS</creator><creator>CHRISTOPHER THOMAS BRAIN</creator><creator>CLAUDIO DAGOSTIN</creator><creator>MILES STUART CONGREVE</creator><creator>GUO HE</creator><scope>EVB</scope></search><sort><creationdate>20141029</creationdate><title>PYRROLOPYRIMIDINE COMPOUNDS AS CDK INHIBITORS</title><author>GILBERT BESONG ; CLINTON A. BROOKS ; CHRISTOPHER THOMAS BRAIN ; CLAUDIO DAGOSTIN ; MILES STUART CONGREVE ; GUO HE</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_PT2331547EE3</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng ; por</language><creationdate>2014</creationdate><topic>CHEMISTRY</topic><topic>HETEROCYCLIC COMPOUNDS</topic><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>METALLURGY</topic><topic>ORGANIC CHEMISTRY</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><toplevel>online_resources</toplevel><creatorcontrib>GILBERT BESONG</creatorcontrib><creatorcontrib>CLINTON A. BROOKS</creatorcontrib><creatorcontrib>CHRISTOPHER THOMAS BRAIN</creatorcontrib><creatorcontrib>CLAUDIO DAGOSTIN</creatorcontrib><creatorcontrib>MILES STUART CONGREVE</creatorcontrib><creatorcontrib>GUO HE</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>GILBERT BESONG</au><au>CLINTON A. BROOKS</au><au>CHRISTOPHER THOMAS BRAIN</au><au>CLAUDIO DAGOSTIN</au><au>MILES STUART CONGREVE</au><au>GUO HE</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>PYRROLOPYRIMIDINE COMPOUNDS AS CDK INHIBITORS</title><date>2014-10-29</date><risdate>2014</risdate><abstract>The disclosed compounds relate to treatments and therapies for protein kinase-associated disorders. There is also a need for compounds useful in the treatment or prevention or amelioration of one or more symptoms of cancer, transplant rejections, and autoimmune diseases. Furthermore, there is a need for methods for modulating the activity of protein kinases, such as CDK1, CDK2, CDK4, CDK5, CDK6, CDK7, CDK8 and CDK9, using the compounds provided herein.</abstract><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext_linktorsrc |
| identifier | |
| ispartof | |
| issn | |
| language | eng ; por |
| recordid | cdi_epo_espacenet_PT2331547EE |
| source | esp@cenet |
| subjects | CHEMISTRY HETEROCYCLIC COMPOUNDS HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY ORGANIC CHEMISTRY PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS |
| title | PYRROLOPYRIMIDINE COMPOUNDS AS CDK INHIBITORS |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-11T20%3A49%3A55IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=GILBERT%20BESONG&rft.date=2014-10-29&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EPT2331547EE%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |